Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Partridge, Ann"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lipsyc-Sharf, Marla, Jain, Esha, Collins, Laura C., Rosenberg, Shoshana M., Ruddy, Kathryn J., Tamimi, Rulla M., Schapira, Lidia, Come, Steven E., Peppercorn, Jeffrey M., Borges, Virginia F., Warner, Ellen, Snow, Craig, Krop, Ian E., Kim, Dewey, Weiss, Jakob, Zanudo, Jorge Gomez Tejeda, Partridge, Ann H., Wagle, Nikhil, Waks, Adrienne G.
Publikováno v:
JCO Precision Oncology; 6/26/2023, Vol. 7, p1-10, 10p
Autor:
Sorouri K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Lynce F; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Feltmate CM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Davis MR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Muto MG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA., Konstantinopoulos PA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA., Stover EH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA., Kurian AW; Stanford University School of Medicine, Stanford, CA., Hill SJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Garber JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Bychkovsky BL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300290.